WHITE PAPER
Defining Digital Transformation in Healthcare
Medical device and pharmaceutical companies are expected to design safe and effective products while managing complexity, reducing costs and risks, and lowering time to market. To address these challenges, companies are evaluating new technologies and supporting processes that bring more agility and effectiveness to their programs, namely research and development (R&D). For example, businesses are rapidly adopting computational modeling and simulation (CM&S) to address near-term development challenges. CM&S helps organizations evaluate complex products from a variety of perspectives using multiphysics simulation software. As the healthcare industry realizes that digital transformation is not limited to electronic health records and the Internet of Things (IoT), digital transformation is being evaluated and implemented to help revolutionize current R&D processes.
